Ivan Horak

Ivan Horak

Plus aucun poste en cours
75 ans
Health Technology
Commercial Services
Consumer Services

Profil

Ivan D.
Horak
is the founder of Tikva Allocell Pte Ltd., established in 2023, where the title held is Chief Executive Officer.
Current jobs include Member at the American Society of Clinical Oncology, Inc., Member at the American Association for Cancer Research, Member at the American Society of Hematology, and Venture Advisor at Israel Biotech Fund.
Former jobs include Director-Oncology Clinical Research & Development at The Janssen Research Foundation from 1996 to 1999, CSO and EVP-Research & Development at Enzon Pharmaceuticals, Inc. from 2009 to 2010, Chief Scientific Officer and Executive VP at Immunomedics, Inc. from 2002 to 2005, Member at the Union for International Cancer Control, Vice President-Clinical Oncology at Pharmacia Corp.
from 1999 to 2002, Principal at the American College of Physicians, Inc., and Chief Medical & Scientific Officer at Tessa Therapeutics Ltd. Education includes a doctorate from the University of Commenius.

Postes actifs de Ivan Horak

SociétésPosteDébut
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Consultant / Advisor -

Anciens postes connus de Ivan Horak

SociétésPosteFin
Directeur Technique/Scientifique/R&D 04/04/2011
IMMUNOMEDICS, INC. Directeur Technique/Scientifique/R&D 02/09/2005
Corporate Officer/Principal 01/05/2002
The Janssen Research Foundation
Directeur Technique/Scientifique/R&D 01/01/1999
President -
Voir l'expérience en détail de Ivan Horak

Formation de Ivan Horak

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

83

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Union for International Cancer Control

Health Technology

Consumer Services

Health Services

Commercial Services

Commercial Services

Commercial Services

The Janssen Research Foundation

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Ivan Horak